Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Draxis | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Draxis

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Draxis Health

1Q Revenues: $21 million (+10%)

1Q Earnings: $2 million (+19%)

Comments: Contract manufacturing revenues for 1Q2007 were $14.2 million (+5%), due to new product introduction activities. The result was weaker compared to the fourth quarter of 2006 due in part to a delay in receiving components for Hectorol production, which resulted in reduced volumes manufactured during the quarter. Sterile products represented approximately 78% of manufacturing revenues compared to 81% for 1Q2006.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters